decan-4-olide has been researched along with Acute Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fontenla, JA; Gonçalves, DA; Krebs, C; Luft, JG; Pereira, P; Pflüger, P; Regner, GG | 1 |
1 other study(ies) available for decan-4-olide and Acute Disease
| Article | Year |
|---|---|
Gamma-decanolactone attenuates acute and chronic seizures in mice: a possible role of adenosine A1 receptors.
Topics: Acute Disease; Animals; Chronic Disease; Disease Models, Animal; Lactones; Male; Mice; Neuroprotective Agents; Receptor, Adenosine A1; Receptors, GABA; Seizures | 2020 |